WOOJUNG BIO Inc (215380) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.033x

Based on the latest financial reports, WOOJUNG BIO Inc (215380) has a cash flow conversion efficiency ratio of -0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-809.75 Million ≈ $-548.76K USD) by net assets (₩24.58 Billion ≈ $16.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 215380 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

WOOJUNG BIO Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how WOOJUNG BIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

WOOJUNG BIO Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of WOOJUNG BIO Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
NextTrip Inc NASDAQ:NTRP	-0.316x
Asian Hotels (East) Limited NSE:AHLEAST	0.039x
Mida Assets Public Company Limited BK:MIDA	-0.061x
Impero AS CO:IMPERO	-1.696x
CrystalGenomics Inc KQ:083790	-0.129x
AGUIA RES LTD AD-20 F:5N91	N/A
Wijaya Karya Bangunan Gedung Tbk PT JK:WEGE	-0.007x
Thai Rubber Latex Group Public Company Limited BK:TRUBB	-0.011x

Annual Cash Flow Conversion Efficiency for WOOJUNG BIO Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of WOOJUNG BIO Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see WOOJUNG BIO Inc market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩29.37 Billion ≈ $19.91 Million	₩-1.13 Billion ≈ $-763.37K	-0.038x	+73.85%
2023-12-31	₩21.97 Billion ≈ $14.89 Million	₩-3.22 Billion ≈ $-2.18 Million	-0.147x	-274.16%
2022-12-31	₩29.72 Billion ≈ $20.14 Million	₩2.50 Billion ≈ $1.70 Million	0.084x	+53.31%
2021-12-31	₩31.46 Billion ≈ $21.32 Million	₩1.73 Billion ≈ $1.17 Million	0.055x	+117.95%
2020-12-31	₩28.03 Billion ≈ $19.00 Million	₩-8.57 Billion ≈ $-5.81 Million	-0.306x	-4007.26%
2019-12-31	₩26.66 Billion ≈ $18.07 Million	₩208.72 Million ≈ $141.45K	0.008x	+134.30%
2018-12-31	₩21.20 Billion ≈ $14.37 Million	₩-483.80 Million ≈ $-327.87K	-0.023x	+82.39%
2017-12-31	₩18.32 Billion ≈ $12.42 Million	₩-2.38 Billion ≈ $-1.61 Million	-0.130x	+5.85%
2016-12-31	₩10.57 Billion ≈ $7.16 Million	₩-1.46 Billion ≈ $-986.04K	-0.138x	--

About WOOJUNG BIO Inc

KQ:215380 Korea Biotechnology

Market Cap

$28.07 Million

₩41.43 Billion KRW

Market Cap Rank

#24034 Global

#1659 in Korea

Share Price

₩2485.00

Change (1 day)

-2.55%

52-Week Range

₩1590.00 - ₩3605.00

All Time High

₩13450.00